SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001654954-20-005070
Filing Date
2020-05-08
Accepted
2020-05-08 06:07:01
Documents
6
Effectiveness Date
2020-05-08

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 cbmg_defr14a.htm DEFR14A 85020
2 IMAGE img001.jpg GRAPHIC 2994
3 IMAGE img002.jpg GRAPHIC 1222
4 IMAGE img003.jpg GRAPHIC 1145
5 IMAGE img004.jpg GRAPHIC 1380
6 IMAGE img005.jpg GRAPHIC 1543
  Complete submission text file 0001654954-20-005070.txt   98259
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-36498 | Film No.: 20858524
SIC: 2836 Biological Products, (No Diagnostic Substances)